Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Published online before print September 26, 2007, doi:10.1212/01.wnl.0000277521.66947.e5)
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
01.wnl.0000277521.66947.e5v1
70/6/425    most recent
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Prabhakaran, S.
Right arrow Articles by Sacco, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Prabhakaran, S.
Right arrow Articles by Sacco, R. L.
Received January 13, 2007
Accepted May 31, 2007

The prevalence and determinants of subclinical brain infarction. The Northern Manhattan Study

S. Prabhakaran MD, MS, C. B. Wright MD, MS*, M. Yoshita MD, R. Delapaz MD, PhD, T. Brown PhD, C. DeCarli MD, and R. L. Sacco MD, MS

From Rush University Medical Center (S.P.), Chicago, IL; Columbia University (C.B.W., R.D., T.B., R.L.S.), New York, NY; University of California-Davis (M.Y., C.D.), Sacramento; and University of Miami (R.L.S.), FL.


* To whom correspondence should be addressed. E-mail: cbw7{at}columbia.edu.

ABSTRACT

Objective: Risk factors for subclinical brain infarcts (SBI) have not been well studied, especially in Hispanic and black populations who may be at higher risk for vascular disease. We examined the prevalence and determinants of SBI in a multiethnic community cohort.

Methods: The Northern Manhattan Study (NOMAS) includes 892 stroke-free participants who underwent brain MRI. Baseline demographic and vascular risk factor data were collected. The presence of SBI was determined from the size, location, and imaging characteristics of the lesion based on fluid attenuated inversion recovery (FLAIR) T1 and T2, and proton density MRI sequences. We calculated the prevalence of SBI and cross-sectional associations with sociodemographic and vascular risk factors, using logistic regression to adjust for relevant covariates.

Results: Among 892 subjects (mean age 71.3 years), 158 (17.7%) had SBI (13.5% had 1 lesion, 4.3% had >1 lesion). Of the total 216 infarcts, most were small (<1 cm, 82.4%) and subcortical (82.9%). SBI prevalence increased with age (<65: 9.7%; 65 to 75: 16.4%; >75: 26.1%), was increased among men (21.3% vs 15.2% in women), and was increased among blacks (24.0% vs 18.1% in whites and 15.8% in Hispanics). The presence of SBI was independently associated with older age (per year: OR 1.06, 95% CI 1.04 to 1.09), male sex (OR 1.79, 95% CI 1.22 to 2.61), and hypertension (OR 2.08, 95% CI 1.35 to 3.22) adjusting for age, sex, race-ethnicity, and vascular risk factors. A significant interaction (p = 0.002) between race and age was observed such that younger black subjects had greater odds of having SBI.

Conclusions: SBI were detected in nearly 18% of subjects in a multiethnic community-based cohort. Age, male sex, and hypertension were independently associated with SBI. Subclinical cerebral infarcts are more prevalent than symptomatic infarcts and may increase the true public health burden of stroke.




This article has been cited by other articles:


Home page
StrokeHome page
C. S. Kase, G. W. Albers, C. Bladin, C. Fieschi, A. A. Gabbai, W. O'Riordan, G. F. Pineo, and on behalf of the PREVAIL Investigators
Neurological Outcomes in Patients With Ischemic Stroke Receiving Enoxaparin or Heparin for Venous Thromboembolism Prophylaxis: Subanalysis of the Prevention of VTE After Acute Ischemic Stroke With LMWH (PREVAIL) Study
Stroke, November 1, 2009; 40(11): 3532 - 3540.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
A. J. Graveling and B. M. Frier
Dementia and Hypoglycemic Episodes in Patients With Type 2 Diabetes Mellitus
JAMA, August 26, 2009; 302(8): 843 - 843.
[Full Text] [PDF]


Home page
StrokeHome page
M. S. Dhamoon, Y. P. Moon, M. C. Paik, B. Boden-Albala, T. Rundek, R. L. Sacco, and M. S.V. Elkind
Long-Term Functional Recovery After First Ischemic Stroke: The Northern Manhattan Study
Stroke, August 1, 2009; 40(8): 2805 - 2811.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
X. Chen, W. Wen, K. J. Anstey, and P. S. Sachdev
Prevalence, incidence, and risk factors of lacunar infarcts in a community sample
Neurology, July 28, 2009; 73(4): 266 - 272.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
D. Tanne and S. R. Levine
Capturing the Scope of Stroke: Silent, Whispering, and Overt
Arch Neurol, July 1, 2009; 66(7): 819 - 820.
[Full Text] [PDF]


Home page
NeurologyHome page
J. Putaala, M. Kurkinen, V. Tarvos, O. Salonen, M. Kaste, and T. Tatlisumak
Silent brain infarcts and leukoaraiosis in young adults with first-ever ischemic stroke
Neurology, May 26, 2009; 72(21): 1823 - 1829.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
R. R. Das, S. Seshadri, A. S. Beiser, M. Kelly-Hayes, R. Au, J. J. Himali, C. S. Kase, E. J. Benjamin, J. F. Polak, C. J. O'Donnell, et al.
Prevalence and Correlates of Silent Cerebral Infarcts in the Framingham Offspring Study
Stroke, November 1, 2008; 39(11): 2929 - 2935.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
K. Rockwood and G. Gubitz
Silent Cerebral Infarction: Are We Listening?
Stroke, November 1, 2008; 39(11): 2919 - 2920.
[Full Text] [PDF]


Home page
NeurologyHome page
W. T. Longstreth Jr and S. E. Vermeer
The growing specter of MRI-defined brain infarcts
Neurology, February 5, 2008; 70(6): 416 - 417.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2007 by AAN Enterprises, Inc.